Elevated DLL4 expression is correlated with VEGF and predicts poor prognosis of nasopharyngeal carcinoma

Zhang, Jia-Xing; Cai, Man-Bo; Wang, Xiao-Pai; Duan, Li-Ping; Shao, Qiong; Tong, Zhu-Ting; Liao, Ding-Zhun; Li, Yang-Yang; Huang, Ma-Yan; Zeng, Yi-Xin; Shao, Jian-Yong
March 2013
Medical Oncology;Mar2013, Vol. 30 Issue 1, p1
Academic Journal
Delta-like ligand 4 (DLL4), one of the transmembranous Notch ligands, is upregulated at the site of tumor growth, particularly during tumor angiogenesis. Expression pattern of DLL4 in nasopharyngeal carcinoma (NPC) and the clinical and prognostic significance remain unclear. In this study, immunohistochemical analysis (IHC) was used to examine the protein level of DLL4 in NPC tissues from two independent cohorts. In the testing cohort (311 cases), we applied the X-tile program software able to assess the optimal cutoff points for biomarkers in order to accurately classify patients according to clinical outcome. In the validation cohort (113 cases), the cutoff score derived from X-title analysis was investigated to determine the association of DLL4 expression with disease-specific survival (DFS). Our results showed that high expression of DLL4 was observed in 134 of 313 (42.8 %) in the testing cohort and 58 of 113 (43.6 %) in the validation cohort. High expression of DLL4 independently predicted poorer disease-specific survival, as evidenced by univariate and multivariate analysis ( P < 0.05). Moreover, DLL4 expression was significantly elevated in distant NPC metastases relative to primary NPC tumors ( P = 0.001). Importantly, we found a significant positive relationship between DLL4 and vascular endothelial growth factor (VEGF) ( P < 0.001). Patients with dual elevated DLL4 and VEGF expression displayed a significant overall survival disadvantage compared to those with dual low expression ( P < 0.05). These findings provide evidence that high expression of DLL4 serves as an independent predictor of poor prognosis in NPC patients.


Related Articles

  • Prognostic value of TROP2 in human nasopharyngeal carcinoma. Guo-Fang Guan; De-Jun Zhang; Lian-Ji Wen; Duo-Jiao Yu; Yan Zhao; Lin Zhu; Ying-Yuan Guo; Ying Zheng // International Journal of Clinical & Experimental Medicine;2015, Vol. 8 Issue 9, p10995 

    Background: There is increasing evidence demonstrating the role of human trophoblast cell surface antigen 2 (TROP2) in cancer development and progression. However, their prognostic value in Epstein-Barr virus (EBV) associated nasopharyngeal carcinoma (NPC) remains to be elucidated. Method: The...

  • Down-regulated ECRG4 expression in breast cancer and its correlation with tumor progression and poor prognosis - A short Report. You, Yanjie; Wang, Fei; Li, Haijun; Qin, Xin; Ran, Yonggang // Cellular Oncology (2211-3428);Feb2016, Vol. 39 Issue 1, p89 

    Background: Recently, we identified the esophageal carcinoma related gene 4 ( ECRG4) as a novel candidate tumor suppressor gene and a promising therapeutic target in nasopharyngeal carcinoma (NPC). In addition, we found that reduced ECRG4 expression in NPC was associated with promoter...

  • Aberrant activation of Hedgehog pathway in Nasopharyngeal carcinoma. Yue, Yongjian; Zhong, Weide; Pei, Genwang; Xiao, Baiyu; Zhang, Guoping; Jiang, Funeng; Zhang, Jinglin; Chen, Changhua; Yang, Peizhou; Dang, Hua; Chang, Hong // Clinical & Experimental Medicine;Nov2013, Vol. 13 Issue 4, p315 

    Nasopharyngeal carcinoma (NPC) is a very common head and neck cancer in southern china. Despite advances in surgical and chemotherapeutic approaches, its prognosis is still not promising. Hedgehog signaling pathway was reported to be involved in a number of cancers including head and neck....

  • Overexpression of ephrinB2 and EphB4 in tumor advancement of uterine endometrial cancers. J Fujimoto // Annals of Oncology;Mar2007, Vol. 18 Issue 3, p485 

    Background: The ligand ephrinB2 and the corresponding receptor EphB4 contribute to tumor growth in various human tumors. This prompted us to study the expression and localization of ephrinB2 and EphB4 in uterine endometrial cancers to analyze the ephrinB2/EphB4 functions against clinical...

  • Increased hepatocyte growth factor and c-Met receptor expression in nasopharyngeal carcinoma. Tian Luan; Yang Yu // International Journal of Clinical & Experimental Medicine;2014, Vol. 7 Issue 12, p5583 

    Hepatocyte growth factor (HGF) and its receptor, c-Met, are associated with invasive tumor growth. This study sought to profile the expression of HGF and c-Met in nasopharyngeal carcinoma (NPC) tissue. Of 221 patients recruited between March 2010 and September 2013, 106 were diagnosed with...

  • Increased expression of CD55 correlates with tumor progression and poor prognosis in nasopharyngeal carcinoma. Yumei Shen; Ruixue Yin; Xiaogang Deng; Hong Shen // Clinical & Investigative Medicine;Feb2012, Vol. 35 Issue 1, pE24 

    Purpose: To analyze the expression of complement delay-accelerating factor (CD55) in nasopharyngeal carcinoma and its correlation with clinicopathologic features, including survival rate. Methods: Eighty-two nasopharyngeal carcinoma tissues were evaluated for CD55 expression using...

  • Upregulation of KLHDC4 Predicts a Poor Prognosis in Human Nasopharyngeal Carcinoma. Lian, Yi-Fan; Yuan, Jing; Cui, Qian; Feng, Qi-Sheng; Xu, Miao; Bei, Jin-Xin; Zeng, Yi-Xin; Feng, Lin // PLoS ONE;3/31/2016, Vol. 11 Issue 3, p1 

    Kelch proteins are implicated in the pathogenesis of many human diseases, including cancer. Nasopharyngeal carcinoma (NPC) is a rare malignancy in most countries, but prevalent in southern China and certain areas of Southeast Asia. In this study, we identified Kelch Domain Containing 4 (KLHDC4),...

  • PTEN Loss Increases PD-L1 Protein Expression and Affects the Correlation between PD-L1 Expression and Clinical Parameters in Colorectal Cancer. Song, Minmin; Chen, Defeng; Lu, Biyan; Wang, Chenliang; Zhang, Junxiao; Huang, Lanlan; Wang, Xiaoyan; Timmons, Christine L.; Hu, Jun; Liu, Bindong; Wu, Xiaojian; Wang, Lei; Wang, Jianping; Liu, Huanliang // PLoS ONE;Jun2013, Vol. 8 Issue 6, p1 

    Background: Programmed death ligand-1 (PD-L1) has been identified as a factor associated with poor prognosis in a range of cancers, and was reported to be mainly induced by PTEN loss in gliomas. However, the clinical effect of PD-L1 and its regulation by PTEN has not yet been determined in...

  • ERBB3 as an independent prognostic marker for nasopharyngeal carcinoma. Tulalamba, Warut; Larbcharoensub, Noppadol; Janvilisri, Tavan // Journal of Clinical Pathology;Aug2014, Vol. 67 Issue 8, p667 

    Aim Although the ERBB proteins have been shown to be associated in many types of human tumours and serve as important cancer therapeutic targets, however, data regarding the expression and clinical relevance of ERBBs in nasopharyngeal carcinoma (NPC) are still conflicting. The aim of this study...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics